Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS

v3.10.0.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Operating expenses:        
Research and development $ 3,754 $ 447 $ 13,193 $ 580
General and administrative 927 1,297 1,913 1,668
Loss from operations (4,681) (1,744) (15,106) (2,248)
Interest income (24) 0 (72) 0
Interest expense 0 93 0 188
Interest expense - related party 0 20 0 81
Change in fair value of convertible notes payable 0 95 0 99
Change in fair value of warrant liabilities 0 454 0 451
Net Loss $ (4,657) $ (2,406) $ (15,034) $ (3,067)
Net loss per common share outstanding, basic and diluted $ (0.45) $ (0.70) $ (1.48) $ (0.95)
Weighted average number of common shares outstanding, basic and diluted 10,251,950 3,459,942 10,176,062 3,242,602